FRNT Grants Stock Options
February 29, 2024 19:19 ET
|
FRNT Financial
TORONTO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- FRNT Financial Inc. (TSXV:FRNT) (OTCQB:FRFLF) (FSE:XZ3) (“FRNT” or the “Company”) announces that it has granted an aggregate of 100,000 stock options (the...
PATTISON Affichage ouvre son appel aux candidatures pour la subvention Elevating Voices de 2024
February 15, 2024 06:00 ET
|
PATTISON Outdoor Advertising LP
Photo ci-dessus : Murale numérique de Royal Bank Plaza, montrant une publicité pour The Forum, récipiendaire d’une subvention Elevating Voices MISSISSAUGA, Ontario, 15 févr. 2024 ...
PATTISON Outdoor Open to Applications for 2024’s Elevating Voices Grant
February 15, 2024 06:00 ET
|
PATTISON Outdoor Advertising LP
Pictured above: Royal Bank Plaza Digital Wall, featuring an advertisement for The Forum, an Elevating Voices Grant recipient MISSISSAUGA, Ontario, Feb. 15, 2024 (GLOBE...
Vandria Awarded €3.8M in Prestigious Innosuisse and Eurostars Grants to Advance Innovative Drug Programs for Age-Related Diseases of the CNS and Muscle
February 08, 2024 03:00 ET
|
Vandria
Vandria is advancing a portfolio of mitophagy inducers to address age-related chronic diseases of the CNS, muscle, lung and liverInnosuisse grant totalling CHF 2.5M (€2.7M) to support early clinical...
Yamaha Empowers E-Bike Communities with Groundbreaking Outdoor Access Initiative Grants
January 18, 2024 15:00 ET
|
Yamaha Motor Corp., USA
MARIETTA, Ga., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Yamaha Motor Corp., USA, proudly announces a groundbreaking chapter in outdoor access with the Yamaha Outdoor Access Initiative (OAI) awarding two...
Water Mission Awarded $1 Million Grant from The Coca-Cola Foundation, Funding Safe Water Programming in Uganda and Tanzania
January 18, 2024 08:59 ET
|
Water Mission
Water Mission, is partnering with The Coca-Cola Foundation on a safe water program grant that will benefit more than 53,000 people in Uganda and Tanzania.
La FDA Américaine Accorde la Qualification de Médicament Orphelin au PTX-252 pour le Traitement de la Leucémie Myéloïde Aiguë (LMA)
January 16, 2024 13:30 ET
|
Hyloris Pharmaceuticals SA
La FDA Américaine Accorde la Qualification de Médicament Orphelin au PTX-252 pour le Traitement de la Leucémie Myéloïde Aiguë (LMA) Le PTX-252 (précédemment appelé agent plécoïdeTM) est une nouvelle...
Orphan Drug Designation Granted to PTX-252 by U.S. FDA for the Treatment of Acute Myeloid Leukaemia (AML)
January 16, 2024 13:30 ET
|
Hyloris Pharmaceuticals SA
Orphan Drug Designation Granted to PTX-252 by U.S. FDA for the Treatment of Acute Myeloid Leukaemia (AML) PTX-252 (previously referenced as a Plecoid™Agent) is a novel molecular entity developed in...
ARC Opens Applications for 2024 Substance Use Disorder Recovery-to-Work Projects
January 08, 2024 14:00 ET
|
Appalachian Regional Commission
Washington, DC, Jan. 08, 2024 (GLOBE NEWSWIRE) -- WASHINGTON, D.C., January 8, 2024—The Appalachian Regional Commission (ARC) issued a Notice of Solicitation of Applications for its Investments...
Operation Come Home provides a welcoming and warm place for youth, thanks to an Ontario Trillium Foundation grant
December 20, 2023 08:26 ET
|
Operation Come Home
Operation Come Home provides a welcoming and warm place for youth, thanks to an Ontario Trillium Foundation grant